FATE Competitors
Fate Therapeutics, Inc.
$1.84
-$0.02(-0.81%)
47
Overall
60
Value
40
Tech
42
Quality
Market Cap
$221.27M
Volume
1.86M
52W Range
$0.95 - $3.23
Target Price
$5.74
FATE competitors: SRPT, BDX, PTCT, RNA, NBIX. Fate Therapeutics, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
FATE Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics, Inc. | $17.82 | $1.91B | $3.27 | - | 47 |
| BDX Becton, Dickinson and Company | $211.88 | $57.71B | $13.30 | 1.98% | 75 |
| PTCT PTC Therapeutics, Inc. | $65.44 | $5.47B | $1.19 | - | 54 |
| RNA Atrium Therapeutics, Inc. | $8.34 | $142.66M | $-4.45 | - | 19 |
| NBIX Neurocrine Biosciences, Inc. | $164.63 | $16.66B | $7.72 | - | 72 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.84 | -0.8% | 1.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |